CD8A and cancer: Programmed Death Ligand-1 (PD-L1) is a membranous protein expressed by tumor cells that can bind to PD1 expressed by lymphocytes to modulate the immune system; this reduces both proliferation and activity of cytotoxic CD8 T cell response to cancer associated antigens, and may allow tumor cells to avoid immune surveillance.